XML 18 R7.htm IDEA: XBRL DOCUMENT v3.19.2
CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Millions
Jun. 30, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 353 $ 147
Accounts receivable, net 737 860
Accrued unbilled revenues 639 755
Inventories 483 548
Regulatory assets 425 464
Derivative instruments 86 87
Prepaid taxes 41 79
Prepayments and other 175 154
Total current assets 2,939 3,094
Property, plant and equipment, net 37,651 36,944
Other assets    
Nuclear decommissioning fund and other investments 2,573 2,317
Regulatory assets 3,145 3,326
Derivative instruments 23 34
Operating Lease, Right-of-Use Asset 1,763 0
Other 490 272
Total other assets 7,994 5,949
Total assets 48,584 45,987
Current liabilities    
Current portion of long-term debt 553 406
Short-term debt 1,597 1,038
Accounts payable 1,057 1,237
Regulatory liabilities 442 436
Taxes accrued 342 450
Accrued interest 180 174
Dividends payable 209 195
Derivative instruments 66 61
Other 614 463
Total current liabilities 5,060 4,460
Deferred credits and other liabilities    
Deferred income taxes 4,319 4,165
Deferred investment tax credits 51 54
Regulatory liabilities 5,139 5,187
Asset retirement obligations 2,647 2,568
Derivative instruments 121 129
Customer advances 198 199
Pension and employee benefit obligations 850 994
Noncurrent operating lease liabilities 1,647 0
Other 190 206
Total deferred credits and other liabilities 15,162 13,502
Commitments and contingencies
Capitalization    
Long-term debt 15,996 15,803
Common stock — 1,000,000,000 shares authorized of $2.50 par value; 514,865,476 and 514,036,787 shares outstanding at June 30, 2019 and Dec. 31, 2018, respectively 1,287 1,285
Additional paid in capital 6,190 6,168
Retained earnings 5,024 4,893
Accumulated other comprehensive loss (135) (124)
Total common stockholders’ equity 12,366 12,222
Total liabilities and equity $ 48,584 $ 45,987